IDYA
Companies
NASDAQ
Ideaya Biosciences Inc.
Health Care
$21.86
-$3.84 (-14.94%)
Price Chart
Overview
About IDYA
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
Market Cap
$2.9B
Volume
27.2M
Avg. Volume
33.3M
P/E Ratio
-7.2169113
Dividend Yield
0.00%
Employees
113.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.80
Moderate Correlation
Volatility
High (0.48)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, IDYA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.9B
Volume27.2M
P/E Ratio-7.22
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 6, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025